CORT
Price
$73.22
Change
-$1.11 (-1.49%)
Updated
Jun 27 closing price
Capitalization
7.76B
31 days until earnings call
GNNSF
Price
$2.20
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Capitalization
4.02B
Interact to see
Advertisement

CORT vs GNNSF

Header iconCORT vs GNNSF Comparison
Open Charts CORT vs GNNSFBanner chart's image
Corcept Therapeutics
Price$73.22
Change-$1.11 (-1.49%)
Volume$11.99M
Capitalization7.76B
Genscript Biotech
Price$2.20
Change-$0.00 (-0.00%)
Volume$500
Capitalization4.02B
CORT vs GNNSF Comparison Chart in %
Loading...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CORT vs. GNNSF commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CORT is a Buy and GNNSF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CORT: $73.22 vs. GNNSF: $2.20)
Brand notoriety: CORT and GNNSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CORT: 788% vs. GNNSF: 60%
Market capitalization -- CORT: $7.76B vs. GNNSF: $4.02B
CORT [@Biotechnology] is valued at $7.76B. GNNSF’s [@Biotechnology] market capitalization is $4.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CORT’s FA Score shows that 1 FA rating(s) are green whileGNNSF’s FA Score has 0 green FA rating(s).

  • CORT’s FA Score: 1 green, 4 red.
  • GNNSF’s FA Score: 0 green, 5 red.
According to our system of comparison, CORT is a better buy in the long-term than GNNSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CORT’s TA Score shows that 6 TA indicator(s) are bullish while GNNSF’s TA Score has 4 bullish TA indicator(s).

  • CORT’s TA Score: 6 bullish, 3 bearish.
  • GNNSF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CORT is a better buy in the short-term than GNNSF.

Price Growth

CORT (@Biotechnology) experienced а +2.58% price change this week, while GNNSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CORT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($7.77B) has a higher market cap than GNNSF($4.03B). GNNSF YTD gains are higher at: 73.228 vs. CORT (45.307).
CORTGNNSFCORT / GNNSF
Capitalization7.77B4.03B193%
EBITDA112MN/A-
Gain YTD45.30773.22862%
P/E Ratio63.67N/A-
Revenue685MN/A-
Total Cash323MN/A-
Total Debt6.84MN/A-
FUNDAMENTALS RATINGS
CORT vs GNNSF: Fundamental Ratings
CORT
GNNSF
OUTLOOK RATING
1..100
350
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
3799
SMR RATING
1..100
4297
PRICE GROWTH RATING
1..100
3835
P/E GROWTH RATING
1..100
948
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CORT's Valuation (83) in the Pharmaceuticals Other industry is in the same range as GNNSF (94) in the null industry. This means that CORT’s stock grew similarly to GNNSF’s over the last 12 months.

CORT's Profit vs Risk Rating (37) in the Pharmaceuticals Other industry is somewhat better than the same rating for GNNSF (99) in the null industry. This means that CORT’s stock grew somewhat faster than GNNSF’s over the last 12 months.

CORT's SMR Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for GNNSF (97) in the null industry. This means that CORT’s stock grew somewhat faster than GNNSF’s over the last 12 months.

GNNSF's Price Growth Rating (35) in the null industry is in the same range as CORT (38) in the Pharmaceuticals Other industry. This means that GNNSF’s stock grew similarly to CORT’s over the last 12 months.

CORT's P/E Growth Rating (9) in the Pharmaceuticals Other industry is somewhat better than the same rating for GNNSF (48) in the null industry. This means that CORT’s stock grew somewhat faster than GNNSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORTGNNSF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
43%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
59%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
66%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
61%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DUSB50.730.04
+0.08%
Dimensional Ultrashort Fixed Income ETF
COMB21.100.01
+0.06%
GraniteShares Blmbrg CmdtyBrdStr NoK1ETF
CPNJ26.14N/A
+0.01%
Calamos Nasdaq-100 Str Alt Prt ETF-Jun
TDF10.04-0.01
-0.10%
Templeton Dragon Fund
BNDD12.40-0.08
-0.66%
Quadratic Deflation ETF

CORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with DNLI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
-1.49%
DNLI - CORT
40%
Loosely correlated
-2.69%
TENX - CORT
38%
Loosely correlated
-1.34%
ARCT - CORT
38%
Loosely correlated
-7.49%
HNSBF - CORT
38%
Loosely correlated
N/A
INSM - CORT
34%
Loosely correlated
-5.11%
More

GNNSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNNSF has been loosely correlated with SILO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GNNSF jumps, then SILO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNNSF
1D Price
Change %
GNNSF100%
N/A
SILO - GNNSF
42%
Loosely correlated
+1.52%
SCNI - GNNSF
26%
Poorly correlated
-7.69%
CORT - GNNSF
25%
Poorly correlated
-1.49%
ORYZF - GNNSF
24%
Poorly correlated
N/A
ARGNF - GNNSF
23%
Poorly correlated
N/A
More